ESC25-1 Podcast Evaluation

Course Title for Certificate

Name*

First NameLast Name

Email*

example@example.com

How many years have you been in practice?

a. Major cardiovascular adverse eventsb Coronary plaque progressionc. Stroked. Intracranial hemorrhage

a. There is a class 1 recommendation to intensify lipid-lowering therapy if LDL-C is >=70 mg/dlb. There is a class 2a recommendation to intensify lipid-lowering therapy if LDL-C is 55 to 69 mg/dlc. If LDL-C is not at goal on high intensity statin therapy, ezetimibe should be added before considering other non-statin lipid lowering therapiesd. A repeat lipid panel should be checked 4-8 weeks after hospital discharge for patients in whom changes to lipid-lowering therapy are made

a. Lp(a) consists of an apoB particle covalently bound to apo(a)b. Statin therapy reduces Lp(a) concentrationc. Higher Lp(a) is associated with the risk of atherosclerotic diseased. Several novel therapeutics that work through RNA interference to lower Lp(a) are in development

a. AZD0780b. Bempedoic acidc. Obicetrapibd. Enlicitide decanoate

Learning Objectives

Rows	Poor	Fair	Good	Very Good	Excellent
Review updated pathophysiology of atherosclerosis, lipid science, current guidelines, and novel therapeutic targets to lower LDL-C and Lp(a) for patients with dyslipidemia
Analyze and contextualize newer clinical trial data for therapies to lower LDL-C levels as presented at ESC2025
Discuss how to utilize combinations of lipid- lowering therapies to improve long term outcomes for dyslipidemia patients with atherosclerosis

Please provide us with feedback regarding your experience at the activity:

Rows	Poor	Fair	Good	Very Good	Excellent
Overall
Content
Usefulness

YesNo

If no, please explain:

YesNoN/A

I gained new strategies/skills/information that my team can apply to practiceI plan to implement new strategies/skills/information in my practiceI will be more competent in my team’s management of patient careI will improve my communication with the healthcare team

What factors beyond clinical care that effect the health of your patients does your team experience?

Attestation:

AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Participants should claim only the credit commensurate with the

extent of their participation in the activity.

Date

Credits